What happened
BioNote filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$19.4M (+13.05% year on year), operating profit of US$583K (−66.97% year on year) and a net loss of US$137M (from a profit a year earlier).
These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.
| Revenue | US$19.4M |
|---|---|
| Revenue vs a year earlier | +13.05% |
| Operating profit | US$583K |
| Net income | −US$137M |
| Period | Q4 2025 (consolidated) |
| Filed | 2026-02-25, Operating results (consolidated) (preliminary) (fair disclosure) |
| Source | DART rcept 20260225801183 → open original filing |
Source: DART. Information only, not investment advice.